Notice from organizers 17 March 2020 After much deliberation and consideration of the Decennial participants’ substantial role in addressing COVID-19 globally, the Society for Healthcare Epidemiology of America’s Board of Trustees unanimously decided the 6th Decennial International Conference on Healthcare Associated Infections will no longer occur March 26 – 30, 2020, in Atlanta, GA. Centers
Due to ongoing concerns over COVID-19 this conference is now available with remote access only SMi’s 22nd Annual Superbugs & Superdrugs 2020 Conference will be held 30-31 March 2020. A Focus on Non-traditional Approaches in the Fight against Antimicrobial Resistance Sponsored by Scynexis CO-CHAIRS FOR 2020: Cara Cassino, Chief Medical Officer, Contrafect & Michael Dawson,
If your small business has strong experience with scientific data processing and outreach, consider sending a contract proposal to establish an Influenza Data Processing and Communication Center (iDPCC). This solicitation recompetes and renames the current influenza DPCC contract to support NIAID’s Centers of Excellence for Influenza Research and Response (CEIRR) network. Submit your proposal by April
COVID-19 has had a profound impact on supply chains for many different critical products worldwide. The pandemic has created major changes in freight flows and has challenged the ability to deliver both medical supplies and food. The National Academies' Transportation Research Board (TRB) is hosting a webinar on Wednesday, April 8, 2020, from 2:00 to
Research Area 001: Development of Radiation/Nuclear Medical Countermeasures (MCMs) HHS-NIH-NIAID-BAA2020-1 This research topic call for proposals is part of the 2020 NIAID Omnibus Broad Agency Announcement. It supports the development of safe and effective MCMs to mitigate and/or treat tissue injuries resulting from exposure to ionizing radiation from a radiological or nuclear incident, thereby leading
HHS-NIH-NIAID-BAA2020-1 Research Area 004: Development of Therapeutic Products for Biodefense, Anti-Microbial Resistant (AMR) Infections, and Emerging Infectious Diseases Supports development of promising new therapeutics to address infections caused by NIAID Category A, B, and C priority pathogens and select bacterial and fungal infections identified in CDC’s report Antibiotic Resistance Threats in the United States 2019 , including optimization, preclinical
HHS-NIH-NIAID-BAA2020-1 Research Area 003: Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases Supports development of vaccines 1) to address antibiotic resistant gram-negative bacteria focusing on but not limited to Burkholderia spp., Pseudomonas aeruginosa, Francisella tularensis, Yersinia pestis, and E. coli, and 2) for emerging viruses and pandemic preparedness that includes but is not limited to alphaviruses
HHS-NIH-NIAID-BAA2020-1 Research Area 005: Advanced Development of Diagnostics for Biothreats and Emerging Infectious Diseases Supports advancing the development of novel, rapid sample-to-answer candidate diagnostic products that will address biodefense and pandemic preparedness. Number of Awards/Total Costs: NIAID estimates that one or more awards may be issued for this Research Area for a total cost of up
Join Trust for America's Health (TFAH) on Wednesday, April 15th for the webinar Protecting Against the Harms of Social Isolation During COVID-19. The ongoing COVID-19 crisis presents unique challenges for the public health and aging sectors. While social distancing protects older adults who are at higher risk for complications from the virus, the practice can
Brought to you by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the current outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. Hear from trusted experts
The FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB) will host this year's annual training course on how to meet GLP requirements in BSL-4 facilities from April 20-24, 2020 at the National Institutes of Health (NIH) in Bethesda, Maryland. Scientists working to develop Medical Countermeasures (MCMs) against several high-priority biological threat agents are
Join the Defence and Security Accelerator for a dial-in on 21 April 2020, 1pm to 2pm. The competition team will provide a short briefing on the Biosensing Across Wide Areas Phase 2 competition followed by an open forum Q&A session. One to Ones There will be two opportunities for One to One dial-in sessions with
Innovators within the fields of pediatric oncology, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150,000 in grant funding; one year of residency at JLABS @ Washington, DC with the use of a bench, workstation, and access to the JLABS @ Washington, DC community; and mentorship from
"After careful consideration, ASM’s Clinical Virology Symposium will not be held May 3-6, 2020. Based on the U.S. Centers for Disease Control and Prevention’s recent recommendation against holding gatherings with 50 or more people for the next eight weeks, we believe this is the responsible decision and in the best interest of our community." The
